Pancreatic Cancer Research

ResearcherWayne State UniversityActive in the last 2 years

Irfana Muqbil

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6889-7035; OpenAlex author ID A5078114527. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 10

  1. Pancreatic ductal adenocarcinoma and edema: reassessing cachexia markers. Co-author DOI 10.21037/jgo-2026-0216↗
  2. Deciphering cellular plasticity in pancreatic cancer for effective treatments. Co-author DOI 10.1007/s10555-023-10164-5↗
  3. Role of noncoding RNAs in pancreatic ductal adenocarcinoma associated cachexia. Last author DOI 10.1152/ajpcell.00424.2022↗
  4. Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-19-1728↗
  5. Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarc… Co-author DOI 10.1080/21541248.2017.1329694↗
  6. DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcin… Co-author DOI 10.3390/cancers11081101↗
  7. Nuclear Export Inhibition for Pancreatic Cancer Therapy. Co-author DOI 10.3390/cancers10050138↗
  8. Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1158/1535-7163.mct-16-0205↗
  9. Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration. Co-author DOI 10.18632/oncotarget.19285↗
  10. The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma. First author DOI 10.3390/jcm5060059↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Asfar Sohail Azmi · 9 shared papers, 2016–2024 · strength 1.09
  2. Philip A. Philip · 8 shared papers, 2016–2024 · strength 0.96
  3. Ramzi M. Mohammad · 8 shared papers, 2016–2022 · strength 0.85
  4. Muhammad Wasif Saif · 1 shared paper, 2026 · strength 0.50
  5. Md. Hafiz Uddin · 2 shared papers, 2022–2024 · strength 0.44
  6. Amro Aboukameel · 5 shared papers, 2017–2020 · strength 0.44
  7. Yiwei Li · 3 shared papers, 2017–2019 · strength 0.28
  8. Bassel F. El‐Rayes · 1 shared paper, 2024 · strength 0.24
  9. Steve H. Kim · 1 shared paper, 2020 · strength 0.09
  10. Anteneh A. Tesfaye · 1 shared paper, 2020 · strength 0.09
  11. Husain Yar Khan · 1 shared paper, 2020 · strength 0.09
  12. Mandana Kamgar · 1 shared paper, 2020 · strength 0.09
  13. Amit Mahipal · 1 shared paper, 2020 · strength 0.09
  14. Maria Diab · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.